Endocrine Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By End User, By Region and Competition, 2020-2030F

Description

The Global Endocrine Testing Market will grow from USD 2.81 Billion in 2024 to USD 4.69 Billion by 2030 at a 8.92% CAGR. Endocrine testing encompasses diagnostic procedures designed to evaluate the function of the endocrine system, which regulates essential hormonal balance throughout the body. These tests measure hormone levels in various biological samples to diagnose and monitor conditions such as diabetes, thyroid disorders, and adrenal insufficiency.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.81 Billion
Market Size 2030	USD 4.69 Billion
CAGR 2025-2030	8.92%
Fastest Growing Segment	Mass Spectroscopy
Largest Market	Europe

Key Market Drivers

The rising prevalence of endocrine disorders fundamentally drives the demand for diagnostic solutions. Conditions such as thyroid dysfunction, diabetes, and adrenal insufficiencies are increasingly widespread globally, necessitating accurate and timely identification for effective management and improved patient outcomes. This escalating burden translates directly into a greater need for comprehensive endocrine testing.

Key Market Challenges

The high cost associated with advanced testing technologies represents a significant impediment to the growth of the global endocrine testing market. This financial barrier directly restricts the widespread adoption of essential diagnostic procedures, particularly in developing regions where healthcare budgets are often limited. Smaller healthcare settings globally also face considerable challenges in acquiring and maintaining these expensive platforms, which consequently curtails their capacity to offer a comprehensive range of endocrine tests.

Key Market Trends

The growth of direct-to-consumer endocrine testing offerings is a significant market trend, enabling individuals to directly access diagnostic services without a traditional physician's referral. This paradigm shift democratizes access to health information, empowers patients in their wellness journeys, and fosters a proactive approach to health management. According to the American Diabetes Association's 2024 Annual Report, nearly 1 in 2 Americans has diabetes or prediabetes, collectively representing 136 million Americans living with these conditions.

Key Market Players

Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
AB Sciex
bioMerieux SA
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America Holdings
Quest Diagnostics Incorporated
Ortho Clinical Diagnostics

Report Scope:

In this report, the Global Endocrine Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Endocrine Testing Market, By Test Type:

Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others

Endocrine Testing Market, By Technology:

Tandem Mass Spectrometry
Immunoassay
Monoclonal & Polyclonal Antibody Technologies
Sensor Technology
Clinical Chemistry
Others

Endocrine Testing Market, By End user:

Hospitals & Clinics
Ambulatory Care Centers
Others

Endocrine Testing Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Endocrine Testing Market.

Available Customizations:

Global Endocrine Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Endocrine Testing Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Test Type (Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Cortisol Test, Insulin Test, Others)
- 5.2.2. By Technology (Tandem Mass Spectrometry, Immunoassay, Monoclonal & Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Others)
- 5.2.3. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Endocrine Testing Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Test Type
- 6.2.2. By Technology
- 6.2.3. By End user
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Endocrine Testing Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Test Type
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By End user
- 6.3.2. Canada Endocrine Testing Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Test Type
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By End user
- 6.3.3. Mexico Endocrine Testing Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Test Type
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By End user

7. Europe Endocrine Testing Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Test Type
- 7.2.2. By Technology
- 7.2.3. By End user
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Endocrine Testing Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Test Type
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By End user
- 7.3.2. France Endocrine Testing Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Test Type
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By End user
- 7.3.3. United Kingdom Endocrine Testing Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Test Type
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By End user
- 7.3.4. Italy Endocrine Testing Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Test Type
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By End user
- 7.3.5. Spain Endocrine Testing Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Test Type
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By End user

8. Asia Pacific Endocrine Testing Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Test Type
- 8.2.2. By Technology
- 8.2.3. By End user
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Endocrine Testing Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Test Type
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By End user
- 8.3.2. India Endocrine Testing Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Test Type
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By End user
- 8.3.3. Japan Endocrine Testing Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Test Type
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By End user
- 8.3.4. South Korea Endocrine Testing Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Test Type
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By End user
- 8.3.5. Australia Endocrine Testing Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Test Type
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By End user

9. Middle East & Africa Endocrine Testing Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Test Type
- 9.2.2. By Technology
- 9.2.3. By End user
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Endocrine Testing Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Test Type
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By End user
- 9.3.2. UAE Endocrine Testing Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Test Type
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By End user
- 9.3.3. South Africa Endocrine Testing Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Test Type
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By End user

10. South America Endocrine Testing Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Test Type
- 10.2.2. By Technology
- 10.2.3. By End user
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Endocrine Testing Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Test Type
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By End user
- 10.3.2. Colombia Endocrine Testing Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Test Type
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By End user
- 10.3.3. Argentina Endocrine Testing Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Test Type
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By End user

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Endocrine Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Abbott Laboratories
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Agilent Technologies Inc.
15.3. Bio-Rad Laboratories Inc.
15.4. AB Sciex
15.5. bioMerieux SA
15.6. DiaSorin S.p.A.
15.7. F. Hoffmann-La Roche Ltd.
15.8. Laboratory Corporation of America Holdings
15.9. Quest Diagnostics Incorporated
15.10. Ortho Clinical Diagnostics